19th International Conference on Alzheimer’s Drug Discovery
The purpose for this annual Alzheimer’s Drug Discovery Foundation (ADDF) conference is to accelerate the development of innovative treatments for Alzheimer’s disease, related dementias and cognitive aging.
Attendees will see the diverse cutting-edge approaches ADDF scientists are undertaking and have opportunities for networking and partnership discussions with academic, industry, and foundation thought leaders.
The two-day meeting is organized around four sub-topics:
II. Neuroprotection and Neural Regeneration;
III. Epigenetics and Cognitive Enhancing; and
IV. Misfolded Proteins and Proteostasis.
|Early Bird before Aug 10||Standard Aug 11 - Sep 16||At door Sep 17 - Sep 18|
|Post-Doctoral Students, Grad. Students||$ 225,00||$ 300,00||$ 375,00|
|Academic / Government||$ 300,00||$ 375,00||$ 425,00|
|Non-Profit Organization||$ 300,00||$ 375,00||$ 425,00|
|Start-up Biotechnology Company||$ 300,00||$ 375,00||$ 425,00|
|Industry and Private Parctice||$ 550,00||$ 650,00||$ 700,00|
|Reception Guest||$ 35,00||$ 35,00||$ 35,00|
|Media||$ 0,00||$ 0,00||$ 0,00|